Clinical practice guidance for juvenile dermatomyositis (JDM) 2018-Update.
Diagnosis
interstitial lung disease
management
myositis-specific autoantibodies
pathophysiology
Journal
Modern rheumatology
ISSN: 1439-7609
Titre abrégé: Mod Rheumatol
Pays: England
ID NLM: 100959226
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
pubmed:
21
1
2020
medline:
3
10
2020
entrez:
21
1
2020
Statut:
ppublish
Résumé
Juvenile dermatomyositis is the most common type of juvenile idiopathic inflammatory myopathy mainly affecting the skin and proximal muscles. We have published the Japanese version of 'Clinical practice guidance for juvenile dermatomyositis (JDM) 2018 'consisting of a review of articles in the field and evidence-informed consensus-based experts' opinion on the treatment strategy in collaboration with The Pediatric Rheumatology Association of Japan and The Japan College of Rheumatology under the financial support by 'Research on rare and intractable diseases, Health and Labor Sciences Research Grants'. This article is a digest version of the Japanese guidance.
Identifiants
pubmed: 31955618
doi: 10.1080/14397595.2020.1718866
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
411-423Commentaires et corrections
Type : ErratumIn